80. Trends Mol Med. 2018 Aug 1. pii: S1471-4914(18)30145-X. doi:10.1016/j.molmed.2018.07.006. [Epub ahead of print]Resident Breast T Cells: The Troops Are Already There.Schalck A(1), Bernatchez C(2), Navin N(3).Author information: (1)Department of Genetics, The University of Texas MD Anderson Cancer Center,Houston, TX, USA; Graduate School of Biomedical Sciences, The University of TexasMD Anderson Cancer Center, Houston, TX, USA.(2)Department of Melanoma Medical Oncology, The University of Texas MD AndersonCancer Center, Houston, TX, USA.(3)Department of Genetics, The University of Texas MD Anderson Cancer Center,Houston, TX, USA; Graduate School of Biomedical Sciences, The University of TexasMD Anderson Cancer Center, Houston, TX, USA; Department of Bioinformatics andComputational Biology, The University of Texas MD Anderson Cancer Center,Houston, TX, USA. Electronic address: nnavin@mdanderson.org.The role of tissue-resident memory T (TRM) cells in breast cancer progression hasbeen difficult to study. Savas et al. [1] (Nat. Med. 2018;24:986-993) usedsingle-cell RNA sequencing to identify TRM cells in triple-negative breast cancerpatients and demonstrated their prognostic value for predicting survival.Copyright Â© 2018 Elsevier Ltd. All rights reserved.DOI: 10.1016/j.molmed.2018.07.006 PMID: 30077643 